학술논문
Results of the phase I open label clinical trial SAKK 06/14 assessing safety of intravesical instillation of VPM1002BC, a recombinant mycobacterium Bacillus Calmette Guérin (BCG), in patients with non-muscle invasive bladder cancer and previous failure of conventional BCG therapy
Document Type
Article
Author
Source
In: OncoImmunology . (OncoImmunology, 1 January 2020, 9(1))
Subject
Language
English
ISSN
2162402X
21624011
21624011